SCHEMBL27612853

SCHEMBL27612853

Cc1ccc(-c2nc(N)nc(N)c2F)cc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
CYP1A1 P04798 1/20 0.41
LMNA P02545 1/20 0.41
CASP1 P29466 1/20 0.41
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
DHFR P00374 3/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4408689 0.89 MAPT (0.45) LMNAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL27631912 0.84 PIK3CG (0.44) TSHRCASP1MAPTSMN1; SMN2HPGD
SCHEMBL27612799 0.83 MAP4K4 (0.43) CYP1A1LMNAMAPTRAB9ASMN1; SMN2
SCHEMBL27613037 0.81 PIK3CG (0.44) NPC1ADORA2AADORA1
SCHEMBL27631713 0.80 ADORA2A (0.51) LMNAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL27612435 0.79 ALDH1A1 (0.48) TSHRALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL27631649 0.78 POLB (0.45) TSHRCASP1ALDH1A1KDM4EMAPT
SCHEMBL4411196 0.77 RAB9A (0.56) ALDH1A1RAB9AKMT2AMEN1ADORA2A
SCHEMBL27631564 0.76 DHFR (0.52) TSHRALDH1A1KDM4EDHFRKMT2A
SCHEMBL4463336 0.76 HEXA (0.47) TSHRALDH1A1RAB9ADHFRADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed